Alzheimer's disease

Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowlym
Fierce Pharma
Tue, 02/11/25 - 09:41 pm
Eisai
Leqembi
Alzheimer's disease
Lilly’s investigational Alzheimer’s to be investigated in prevention trial
Clinical Trials Arena
Wed, 02/5/25 - 11:14 am
clinical trials
Eli Lilly
remternetug
Alzheimer's disease
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Marketscreener
Fri, 01/31/25 - 11:16 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Biogen, Eisai Win Nod for Monthly Leqembi Maintenance Amid Stagnant Sales
BioPharma Dive
Mon, 01/27/25 - 11:24 am
Biogen
Eisai
Leqembi
Alzheimer's disease
FDA
J&J is all in on tau-targeted Alzheimer’s candidates. Will the approach lead to more effective treatments?
Pharma Voice
Fri, 01/24/25 - 11:32 am
JNJ
anti-tau
Alzheimer's disease
R&D
Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
Fierce Pharma
Tue, 01/21/25 - 07:13 pm
Novo Nordisk
Eli Lilly
GLP-1 agonists
Wegovy
Ozempic
Zepbound
Mounjaro
Alzheimer's disease
arthritis
New Acquisition to Strengthen Lantheus’s Position in Alzheimer’s Radiodiagnostic Market
Medical Devices and Diagnostics Industry
Mon, 01/13/25 - 11:08 am
Lantheus
Medtech
M&A
Life Molecular
Alzheimer's disease
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
Clinical Trials Arena
Fri, 01/10/25 - 11:18 am
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Alzheon
Cassava lays off 3rd of workforce in wake of phase 3 Alzheimer's fail
Fierce Biotech
Wed, 01/8/25 - 11:17 am
Cassava Sciences
layoffs
Alzheimer's disease
simufilam
10 clinical trials to watch in the first half of 2025
BioPharma Dive
Thu, 01/2/25 - 11:42 am
clinical trials
Eli Lilly
cardiovascular disease
Arvinas
protein degradation
Vera Therapeutics
IgA nephropathy
Novarts
pelacarsen
Entyvio
IBD
Novo Nordisk
Alzheimer's disease
Beam Therapeutics
sickle cell disease
COMPASS Pathways
psychedelics
Moderna Therapeutics
Verve Therapeutics
high cholesterol
BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program
Stock Titan
Thu, 12/19/24 - 10:21 am
Bristol Myers Squibb
BioArctic
BAN1503
BAN2803
Alzheimer's disease
GSK and Muna Therapeutics partner to develop new treatments for Alzheimer’s
Biopharma Reporter
Tue, 12/10/24 - 11:33 am
GSK
Muna Therapeutics
Alzheimer's disease
GSK inks 2nd neuro pact in weeks, this time with Danish biotech Muna in Alzheimer's
Fierce Biotech
Thu, 12/5/24 - 11:49 am
GSK
Muna Therapeutics
Alzheimer's disease
Alector lays off 17% of staff after AbbVie-partnered Alzheimer's asset fails phase 2
Fierce Biotech
Tue, 11/26/24 - 11:05 am
Alector
AbbVie
Alzheimer's disease
clinical trials
layoffs
AL002
Cassava flunks phase 3 Alzheimer's test, triggering early end of 2nd trial and stock crash
Fierce Biotech
Mon, 11/25/24 - 09:49 am
Cassava Sciences
clinical trials
Alzheimer's disease
simufilam
New Alzheimer's prevention trial receives $74.5 million NIH grant
Drugs.com
Sun, 11/17/24 - 09:22 pm
Eli Lilly
Alzheimer's disease
NIH
clinical trials
Eisai wins over European regulators on Alzheimer’s drug Leqembi
BioPharma Dive
Thu, 11/14/24 - 10:28 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
BioSpace
Sun, 11/10/24 - 09:27 pm
Eisai
Biogen
Leqembi
earnings
Alzheimer's disease
Eisai dials back forecasts for Alzheimer's drug Leqembi
Pharmaphorum
Fri, 11/8/24 - 11:38 am
Eisai
earnings
Leqembi
Alzheimer's disease
Cassava’s Alzheimer’s drug nears P3 readout, but SEC scandal casts long shadow R&D
Pharmaphorum
Wed, 11/6/24 - 11:35 am
Cassava Biosciences
Alzheimer's disease
SEC
clinical trials
simufilam

Pages